A Study of Herceptin (Trastuzumab) in Combination With 2nd-Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.
Clinical trial NCT00444587 · COMPLETED
Trial details
- NCT number
- NCT00444587
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2011-08-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.